title: Phencyclidine (PCP)-like inhibition of N-methyl-D-aspartate-evoked striatal acetylcholine release, H-TCP binding and synaptosomal dopamine uptake by metaphit, a proposed PCP receptor acylator.
abstract: The phencyclidine (PCP) receptor acylator, metaphit, has been reported to act as a PCP antagonist. Recent electrophysiological and behavioral assessments of metaphit action have revealed, however, that this compound can also act as a PCP-like agonist. The present study examined the effects of metaphit on the inhibition of N-methyl-D-aspartate (NMDA)-induced 3H-acetylcholine (ACh) release, 3H-TCP binding and synaptosomal 3H-dopamine (DA) uptake in the rat striatum. Preincubation of striatal slices for 10 min in the presence of metaphit, followed by a prolonged washout, produced a concentration-dependent inhibition of the ACh release evoked by 300 microM NMDA. At high concentrations, preincubation with PCP also resulted in inhibition of this measure. However, this could be reduced by extending the washout period, a procedure which had no effect on the inhibition produced by metaphit. At 10 microM, metaphit resulted in a 53% reduction in NMDA-evoked ACh release while PCP had no effect under identical conditions. Preincubation of slices in 10 microM PCP and metaphit reduced the metaphit inhibition by 62%. The effects of PCP and metaphit, alone or in combination, on NMDA-induced ACh release were paralleled by a loss of 3H-TCP binding sites in striatal tissue incubated under identical conditions suggesting that metaphit exerts long-lasting agonist-like actions on PCP receptors coupled to NMDA receptors. Although these results do not explain the ability of metaphit to antagonize PCP effects in other assays, we did observe that preincubation of striatal synaptosomes with metaphit also resulted in an irreversible inhibition of 3H-DA uptake. These data are discussed in relation to the interaction of metaphit with PCP receptors in various systems.
authors.affiliation: Department of Pharmacology and Toxicology University of Texas Medical Branch, Galveston 77550.
authors.forename: L D
authors.initials: LD
authors.lastname: Snell
authors.forename: K M
authors.initials: KM
authors.lastname: Johnson
authors.forename: S J
authors.initials: SJ
authors.lastname: Yi
authors.forename: R A
authors.initials: RA
authors.lastname: Lessor
authors.forename: K C
authors.initials: KC
authors.lastname: Rice
authors.forename: A E
authors.initials: AE
authors.lastname: Jacobson
mesh_terms: D000109:Acetylcholine / Q000378:metabolism; D000215:Acylation; D000818:Animals; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D008297:Male; D016202:N-Methylaspartate; D010622:Phencyclidine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D017981:Receptors, Neurotransmitter / Q000378:metabolism*; D017478:Receptors, Phencyclidine; D013574:Synaptosomes / Q000378:metabolism; D014316:Tritium; D014317:Tritolyl Phosphates / Q000378:metabolism
chemical_list: D017981:Receptors, Neurotransmitter; D017478:Receptors, Phencyclidine; D014317:Tritolyl Phosphates; D014316:Tritium; D001224:Aspartic Acid; D016202:N-Methylaspartate; C044705:metaphit; D010622:Phencyclidine; D000109:Acetylcholine; D004298:Dopamine